About Aurex Laboratories
Aurex Laboratories is a Healthcare company based in Windsor (Canada) founded in 2014, and was acquired by Apnar Pharma in February 2022. Drug manufacturing for multiple therapeutic areas is conducted through RD. Its chief executive, as recorded, is Ranga Aravapalli. Aurex Laboratories offers products and services including DEPO288 Platform and Promotions Service. Its focus areas include Diversified Pharmaceuticals. Its legal entity in India is Aurex Laboratories Private Limited (U24240TG2015PTC100187).
Company details
Aurex Laboratories was established in 2014 in Windsor, Canada, within the pharmaceutical sector. Research and development efforts are directed toward the manufacturing of drugs across various therapeutic areas. Operations encompass the production of pharmaceutical products to support diverse medical needs. Leadership is provided by Ranga Aravapalli, serving as CEO. The companys domain, aurexlabs.com, facilitates its activities in this field.
- Headquarters Windsor, Canada
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website aurexlabs.com
- Social LinkedIn
- Acquired by Apnar Pharma (Feb 2022)
- Legal Name Aurex Laboratories Private Limited
- Date of Incorporation 11 Aug, 2015
- Jurisdiction Hyderabad, Telangana, India
- Indian entity revenue₹48,503
FY 2025 · +5% YoY
- Indian entity net loss-₹1.59 Cr
FY 2025 · -32866% margin
- Indian entity EBITDA-₹1.59 Cr
FY 2025 · -32862% margin
- Investors
- Acquired byApnar Pharma
(Feb 2022)
Associated legal entities of Aurex Laboratories
Aurex Laboratories operates through Aurex Laboratories Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Aurex Laboratories Private Limited CIN U24240TG2015PTC100187 | Active | 11 Aug 2015 | Hyderabad, Telangana | ₹0.0 Cr | 2 | View details |
Products & Services of Aurex Laboratories
Aurex Laboratories offers a comprehensive portfolio of products and services, including DEPO288 Platform and Promotions Service.
Platform for accessing online games with secure login.
Offers vouchers and discounts for gaming activities.
Investors in Aurex Laboratories
Aurex Laboratories has secured backing from 1 investor. Prominent investors backing the company include Apnar Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Produces high-quality pharmaceutical products including tablets, capsules, syrups, and injectables. | 2014 | apnarpharma.com | Chino, United States |
Investor details for Aurex Laboratories
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Aurex Laboratories Private Limited (Aurex Laboratories)
Aurex Laboratories Private Limited is the primary company behind Aurex Laboratories. The board of Aurex Laboratories Private Limited currently have 2 directors; the longest-serving is Kanchana Durga Arvapally, appointed in 2015. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Kanchana Durga Arvapally DIN 06503321 | Director | 11 Aug 2015 | 11 yrs 2 mo | Aurex Laboratories Private Limited |
| Varun Aravapalli DIN 09447137 | Director | 24 Dec 2021 | 4 yrs 9 mo | Aurex Laboratories Private Limited |
People of Aurex Laboratories
1 people are tracked at Aurex Laboratories (1 in leadership).
| Name | Role | Group |
|---|---|---|
Ranga Aravapalli | CEO | Leadership |
Complete people profiles for Aurex Laboratories
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Aurex Laboratories
Figures of Aurex Laboratories Private Limited, the primary company behind Aurex Laboratories, for FY 2025. Revenue was ₹48,503 (+5% year on year). Net loss was -₹1.59 Cr (-32866% margin). EBITDA was -₹1.59 Cr (-32862% margin). Revenue has grown at a compounded annual rate of -79% over three years and -66% over five years.
- ₹48,503Revenue · FY 2025 · +5% YoY
- -₹1.59 CrNet loss · -32866% margin
- -₹1.59 CrEBITDA · -32862% margin
- ₹1 LakhPaid-up capital
- -79%Revenue CAGR, 3 years
- -66%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Aurex Laboratories Private Limited are on its company page.
Detailed financial statements for Aurex Laboratories
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Aurex Laboratories
2 dated milestones of Aurex Laboratories across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Aurex Laboratories is founded.
- Exit Acquired by Apnar Pharma.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Aurex Laboratories
Complete news archive for Aurex Laboratories
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aurex Laboratories
Aurex Laboratories was founded in 2014.
Aurex Laboratories is headquartered in Windsor, Canada. It is registered at Windsor, Ontario, Canada.
Ranga Aravapalli is the CEO of Aurex Laboratories, as recorded in our data.
The primary company behind Aurex Laboratories, Aurex Laboratories Private Limited, reported revenue of ₹48,503 for FY 2025, up 5% year on year.
Aurex Laboratories was established in 2014 in Windsor, Canada, within the pharmaceutical sector. Research and development efforts are directed toward the manufacturing of drugs across various therapeutic areas. Operations encompass the production of pharmaceutical products to support diverse medical needs. Leadership is provided by Ranga Aravapalli, serving as CEO. The companys domain, aurexlabs.com, facilitates its activities in this field.
Aurex Laboratories offers DEPO288 Platform and Promotions Service.
Aurex Laboratories has 1 investor. Key investors include Apnar Pharma.
Aurex Laboratories operates through Aurex Laboratories Private Limited.
Yes. Aurex Laboratories was acquired by Apnar Pharma in February 2022.
The legal entities of Aurex Laboratories currently have 2 directors, including Kanchana Durga Arvapally, Varun Aravapalli.